A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer

Clinical trial NCT04538742 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04538742
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2020-12-28
Primary completion: 2025-01-31
Enrollment: 245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.